A single course of carboplatin remains a reasonable option in Stage 1 seminoma of the testis
At 6.5 years median follow up, the MRC and EORTC study comparing para-aortic radiotherapy to a single course of carboplatin continues to show the non-inferiority of adequate dose carboplatin and a reduced rate of second testicular germ cell tumours....
Want to read complete article? Please Sign in or Register.